Jeff Nielson | TalkMarkets | Page 3
Independent Information Services Professional
Contributor's Links: Psychedelic Stock Watch
Jeff Nielson is a business writer from Vancouver, Canada who covers markets and the economy. With an academic background in economics and law, he provides a unique perspective in economic trends and market opportunities. In covering markets, Jeff has worked with over 100 public companies spanning ...more

Articles

Latest Posts
33 to 48 of 89 Posts
Psychedelic Drug Development Or Clinics: Which Is The Better Path To Investor Profits?
Drug development provides investors with home-run potential. Psychedelics-assisted mental health clinics have a potential consumer base of over 1 billion patients. But which offers the greatest opportunity?
Will Court Challenges Lead To Psychedelics Legalization?
If governments don't expedite (legal) access to psychedelics-based medicine, the courts could intervene to expedite this process.
What Field Trip’s Huge Financing Tells Investors
In a rocky week for global markets – and psychedelic stocks – investors might have missed some big news.
U.S. Psychedelic Drug Legalization: Urgency Or Inertia?
Why is near-term legalization of (some) psychedelic drugs in the U.S. a legitimate possibility? Because the Mental Health Crisis is now threatening the political interests of the Dinosaurs of Congress.
Countdown To Psychedelic Stock Rally, Part 2: Sector-Wide Catalysts
Explores several sector-wide catalysts that could ignite the next rally in psychedelic drug stocks.
SKRR Strikes Major Gold Intercept On Olson Project
SKRR Exploration reported the assay results from its first drilling on the Company’s flagship Olson Gold Project. The results fall in between those two extremes.
Countdown To Psychedelic Stock Rally, Part 1: Individual Drivers
Recent sideways trading in psychedelic drug stocks could end at any time. Let's look at the individual drivers that could launch these companies into new rallies.
The Road To Psychedelics Legalization, Part 2: Psilocybin And MDMA
After 50 years of drug prohibition, psilocybin and MDMA are destined to be the first two psychedelic substances legalized for medicinal use.
Why Gold Is A Superb Investment Strategy
Thanks to central bank monetary policies, gold is in a permanent bull market. Learn why (and how) the world's ultimate Safe Haven is still a superb investment strategy.
The Road To Psychedelics Legalization, Part 1: Psychedelics Vs. Cannabis
While cannabis legalization has encountered serious roadblocks in many jurisdictions, the path to legalization for psychedelic drugs looks much different.
Leviathan Gold Goes Public With Exciting High-Grade Gold Opportunity
Leviathan Gold is a junior gold exploration company spun-off from Fosterville South Exploration about to go public, exploring for gold in Australia near Kirkland Lake's fabulous Fosterville Mine.
Follow The Money: US$500+ Million In New Psychedelics Financing Powering Massive Growth
The huge dollar totals here are only half the story. Equally important is the progress in raising capital for individual companies.
Psychedelics Revolution Gaining Breadth And Momentum
As investment capital floods into the psychedelics sector, psychedelic drug companies are rapidly building out an industry – vertically and horizontally.
New Psychedelics ETF Is Another Sector Milestone
The first psychedelic stock ETF is about to commence trading. Yet another milestone for an emerging industry with a very bright future.
The Year In Review For Psychedelic Drug Stocks: 2020
In 2020, the psychedelic drug industry burst onto the radar of investors. As psychedelic drug research exploded and new capital has flooded into this sector, a vibrant core of public companies has commenced trading.
Will Psychedelic Stocks Be The New ESG Favorites For 2021?
For socially-conscious investors, psychedelic drug stocks are very strong candidates for ESG investing.
33 to 48 of 89 Posts